Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Key Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (82)
Cancellation by sponsor (66)

Date

2024 (6)
2023 (11)
2022 (7)
2021 (6)
2020 (5)
2019 (6)
2018 (11)
2017 (7)
2016 (2)
2015 (40)
2014 (4)
2012 (4)
2011 (2)
2010 (2)
2009 (6)
2008 (3)
2007 (1)
2006 (3)
2005 (1)
2004 (2)
2003 (1)
2001 (2)
1999 (1)
1995 (1)
1994 (2)
1993 (1)
1992 (3)
1991 (8)

Results for "[search-keyword]"

Search

Sponsor content

148 result(s) found, displaying 31 to 40

Blistex Lip Conditioning Balm (new formulation) (319296)

26 June 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Blistex Lip Conditioning Balm (new formulation).
Blistex Lip Conditioning Balm Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
OsteVit D & Calcium Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
Dozile Natural Sleep Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
Blistex Lip Conditioner SPF15 Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
Blistex Five Way Lip Protection Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
OsteVit-D Capsules Cancelled under Section 30(1)(c) of the Act

5 March 2021

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
VIG HIGH POTENCY (new formulation) Cancelled under Section 30(1)(c) of the Act

30 June 2020

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd
Blistex Ultra Lip Balm (288570)

4 May 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Blistex Ultra Lip Balm.
BLISTEX ULTRA LIP BALM (NEW FORMULATION M2) Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Key Pharmaceuticals Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.